Category: United States
-
Podcast: interview with Dr. Bowman Heiden on role of SEPs in economics, policy intervention, cultivating a transatlantic IP career
Dr. Bowman Heiden is the Executive Director of the Tusher Strategic Initiative for Technology Leadership at UC-Berkeley. He is also the Co-Director of the Center for Intellectual Property (CIP) at the University of Gothenburg, and co-chair of the Technology, Innovation, and Intellectual Property program at the Classical Liberal Institute at the NYU School of Law. …
-
Here’s how Apple is bringing back pulse oxymetry in the U.S. with a workaround that keeps clear of Masimo’s ITC import ban patents
Apple has made headway against Masimo with a clearance decision by U.S. Customs and Border Protection for a designaround.
-
The Trump Administration is not above the law — but neither is Harvard: patent march-in rights
Whatever allegations the Trump Administration makes against Harvard and its affiliates may ultimately have to be discussed in court. But Harvard’s compliance is not beyond doubt.
-
BREAKING: GSK cashes in on license deal as CureVac settles U.S. patent dispute with acquirer BioNTech and Pfizer for $790M+
Pfizer and BioNTech have settled their three-year COVID vaccine-related patent infringement dispute with CureVac in the U.S., granting the latter and its licensing partner GSK $370 million each.
-
NPEs file as few as 10% of ITC Section 337 complaints: agency counsel
Between 70% and 90% of ITC investigations are initiated by non-NPEs, with those numbers generally increasing, while there is a notable shift in the NPEs that do file complaints toward being more innovation-focused.
-
Chanel sued over augmented reality patent in Western District of Texas: virtual try-on
Zugara’s patent suit against Chanel is the latest in a string of infringement disputes in the Augmented Reality industry and the second targeting virtual try-on technologies in the beauty sector.
-
An interview with Bayer’s outgoing head of IP Dr. Jörg Thomaier, new head Dorian Immler
Following three decades at Bayer, Dr. Jörg Thomaier is retiring as head of IP, super confident that his replacement Dorian Immler will have the energy and drive to make the changes that the department needs to keep prospering.
-
Litigation funding increasingly “unnecessarily” complex because of predatory litigation funding myths, SIM IP director says
Firms like Sauvegarder Investment Management can help patentees assert their assets in this increasingly expensive system, but would prefer to buy the patents that they enforce first, SIM IP’s Jennifer Burdman said on an online panel today.
-
Netlist files fresh U.S. patent infringement suit against Samsung following demise of memory module partnership
Netlist has sued Samsung and one of its distributors, Avnet, over the alleged infringement of one of its memory module patents.
-
China holds a “paramount” central position in global patent licensing: Via LA’s Jane Bu on move to Shanghai
The Chief Licensing Officer says her three-month move to Shanghai proves the depth of the pool administrator’s commitment to China and the wider Asian region.